MolNFT v1 · #55125 · protein
Crystal structure of the second glutaredoxin domain of human TXNL2
2YAN · Glutaredoxin-3: “Crystal structure of the second glutaredoxin domain of human TXNL2”. X-ray diffraction, 4 ligands (GSH, FE, SO4), 2 pockets (best druggability 0.48). MolNFT v1 #55125 on GenesisL1: 3D structure, binding sites and…
- PDB
- 2YAN
- Type
- protein
- Length
- 210 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Glutaredoxin-3
- UniProt
- O76003
- Ligands
- GSH, FE, SO4, CL
- Pockets
- 2 · best druggability 0.48
Structure
x-ray diffraction · 1 distinct chain · 49% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Glutaredoxin-3 | protein | 105 | 49% helix, 18% strand | O76003 |
Ligands and binding sites
- GSH · Glutathione · ligand · 2 copies · chains A, B
- FE · Fe (III) ion · metal · chains A
- SO4 · Sulfate ion · ion · chains A
- CL · Chloride ion · ion · chains A
- EDO · 1,2-ethanediol · additive · 7 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 146 | 0.48 | 0.78 | 17 | EDO |
| 2 | 61 | 0.46 | 0.84 | 15 | empty |
Interfaces
1 interface between chains.
- A–B · 671 Ų buried · 9 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 covalent (covalent ligand).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O76003
- Elsewhere: RCSB PDB 2YAN · PDBe 2YAN · UniProt O76003
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.